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The effects 0 ng on the human heart are generaiiy 
characterized reduced ability of the myocardium to 
adapt to a mechanical stress, aIlthou& rest cardiac perfor- 
mance is largely prese (I). Moreover, the lack of in!Iam- 
matory cells and toll accumulation in the myocardial 
interstitium suggests hat structural integrity is mostly pre- 
served, and this phenomenon may correlate with normal 
baseline ventricular pump function in the elderly (2). How- 
ever, quantitative studies have shown that a continuous loss 
of myocytes occurs with aging, and this phenomenon is 
accompanied by reactive hypertrophy of the remaining cells, 
tending to compensate for the loss of muscle mass (2). As a 
result of cellular enlargement, wall thickness remains essen- 
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tially constant, and gross ventricular natomy isnot altered. 
Nevertheless, ventricular hypertrop y is present, as deter- 
mined by myocyte nlargement, a~thoMgh notby vent 
weight (2). 
On the assumption that limitations may exist in the 
growth reserve of the myocardium, yocyte loss and cellu- 
lar hypertrophy should affect his adaptive mechanism by 
decreasing the number of viable cells and utilizing in part 
their growth response capacity. These structural modihca- 
tions may constitute the basis for the greater deleterious 
impact of a systolic and diastolic overload on the aged heart 
(1). Such a possibility has been documented xperimentally 
(ES), and the attenuation in the growth reaction of the old 
myocardium has been linked to defects in the molecular 
control of myocyte hypertrophy (6). It cannot be excluded, 
however, that under tbese conditions myocytes may reex- 
press their ability to synthesize DNA and undergo cell 
division, because myocyte proliferation in pathologic states 
of the heart has been found tc be accompanied by little or no 
myocyte hypertrophy in both hum s (7-9) and animal 
models (10-12). Because it has been demonstrated that 
myocyte cellular hyperplasia represents he major growth 
process of the senescent failing heart in rodents (12~14), the 
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II 26 hearts were 
the atria! ventricular g  
cot ~e~e~d~cu~ar~y to 
Vent~c~~ar mass vohme was 
cart, the two ventricles 
thickness was estimated by averaging 10 equally spaced 
measurements from each of the two middle tissue sections of
each ventricle, which represented he ort~on halfway be- 
tween the base and the These determinations were 
restricted tothe free wall th ventricles. The trabeculae 
carnae and papillary muscles attached to the wall were not 
included in the assessment of wall thickness. Subsequently, 
the two middle slices of the free wall of eat 
cut radially to obtain tissue fragments e,;te 
ial to the epicardiac surface. These samples were 
fixed in 10% buffered formalin and embedaed in glycol 
methacrylate. At the time of embedding, each specimen of 
the left ventricle was divided into two regions comprising the 
epimyocardium and endomyocardium. This procedure was 
necessary because of the difficulty of embedding the thick 
left ventricular wall in a single mold. The fragments ofthe 
e of each ventri 
areas adjacent tothe nuclear edges were measur 
The volume percent of myocytes inthe tissue V(m), was 
obtained by courting the fraction of points overlying the 
myocyte compartment in each of the 100 fields ex 
Similarly, the volume n of the i~terstit~~m was evaluated 
from the ntimber of overlying this tissue component. 
ned in ~o~g~t~di~~~~y 
oriented myocytes at a magnification of x 1,250 by measu~~g 
groups of 10 sarcomeres each. Forty such me~urements were 
made in each ventricle. These values were collected in the 
cardium V(m), were 
ment of the number 
ventricle using the equation I (IO-12,17,18): 
N(n), = N(n)AID,. Ul 
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Table 1. Characteristics of Study Subjects 
Control 
Hearts 
Age (yr) 76 2 6.6 
(66-87) 
Body weight (kg) 69 i: 9.4 
(W-86) 
Height (cm) 169 + 6.5 
(160-185) 
Body surface area (rn? 1.79 c 0.13 
(I.%2.04) 
Total heart weight @I* 347 f; 39 
(280-430r 
Hypertrophied 
Hearts 
80 f 4.3 
(74-87) 
74 + 8.7 
(56-W) 
170 + 6.3 
(160-185) 
1.8s * 0.14 
(1.58-2.12) 
Diierence 
0% 
6 
7 
0 
3 
Vz!ke 
NS 
NS 
NS 
MS 
*Total heart weight includes left and right ventricles, IeR and right atria. ori in of great vessels and epic 
Resuhs are presented as mean VdUCS 2 <II frm 
regate volume of myocy~es in the veat~c~e V(rn~~ 
&ved from the ventricular volume meas~reme~t 
V and V(m),: 
V(m), = V X V(m),. I21 
The total number Of myoCyte nUCk?i in the ventricle N(n)T 
was computed from N(n), and V(m)+ 
N(n)r = N(n), x V(mh. I31 
V(rnh divided by N(n), yielded the average myocyte cell 
volume per nucleus V(m), in the ventricle in each heart: 
V(m), = V(m)$N(n)T. I41 
perfotmed in our laborat 
for morphometric data c
conservative estimate ofnecessary counts than more specific 
(20) and profile counts 
ity amon patients ina 
en 8tuup is at least 1 counting errors in each subject 
ould also be limited by same order of magnitude forthe 
least fkquent structure (18). Specifically, in each left ventricle 
of each ypertrophied heart the sampling of1 
in the collection of a total number of nuclei 
minimum of152 to 206. According tothe Poisson s 
amount of sampling yields asampling error of 8.1% and 7.0%, 
respectively. Correspondii values for the right ventricle were 
32 nuclei, which yield sampling errors of 7.3% and 
total number of nuclei counted in the left and right 
ventricles of the 13 hypertrophied hearts were 2,327 and 2,717, 
which implies amplir~ errors of 2.1% and 1.9%. In control 
subjects, the number of nuclei counted in the lefi ventricle of
each eart varied from 158 to 184 and in the right ventricle from 
154 to 1%. Thus, sampling errors were 8.O%, 7.4%, 8.1% and 
7.1%. Because a total of 2,223 and 2,230 nuclei were counted in
the 13 left and right ventricles, sampling error was 2.1% in both 
cases. Significantly smaller sampling emors were obtained for 
two measurements was 
had to weigh ~450 g. Although as listed in Table 
interval in patients with cardiac by~~ro~hy varied from a 
minimum of74 to a maximum of 87 years, the 66-year limit 
had to be used to collect an identical group of hearts from 
normal subjects with height, body weight and body surface 
comparable to those of the hy~~~hy group. In control 
subjects, age varied from 66 to 87 years, ave ing 76 years. 
Because the mean age in patients with cardiac hypertrophy 
was 80 years, there was  4-year difference between the two 
groups. However, this difference was not statistically signif- 
icant. Both groups included 10 men and 3 women. 
Gross cardiac weight was obtained after careful removal 
of blood from the four chambers but included atrial weight, 
epicardial fat, initial portions of the great vessels and valvu- 
lar structures. Such a protocol was used with the intention of
making the selection simple and as objective as possible. 
Subsequently, the coronary arteries were examined to ex- 
clude reductions ofvessel diameter >30%. This assessment 
was performed by sectioning the coronary arteries perpen- 
terminal evelnt responsible for their d 
phy was seen to be associated with valvular defects in six 
patients and essential hy~e~e~sio~ in four. In three patients, 
no history or pathologic changes consistent with di 
forms of cardiovascular disease were documented. In most 
of the patients in this group, death was of primary cardiac 
origin or related to the impaired heart condition. From 
available i~o~~atio~~ it was not possible to establish the 
time of onset of the aortic or itral valve alterations orthe 
duration of the hypertensive state. Whether prolonge 
apeutic treatment had been used in these patients was also 
diEcult to determine. In the three &ems with senile aortic 
calcification and in the three patients with mitral insu 
ciency of rheumatic origin, hypertension and diabetes were 
absent. In one of the four patients with systemic hyperten- 
sion, angiotensin-converting enzyme inkibitors had been 
ventricle as a resul 
disease processes li ted in ‘Iable 2. These measurement? were 
all obtained after careful dissection f the e 
ventricular weight inc. 
ventricular weight by 55 
tions led to a 
heart weight. 
statistically differem inthe two grou 
in the ratios of cardiac 
were corn~a~~le to those seen in te 
asurements of ventricular wall thickness 
posterior aspects of the 
ular wall thickened in diseased bearts by 1 
13.58 r 1.52 mm; hypertrophie 5 I 2.17 mm), 8% 
(normal 13.52 + 1.48 mm; hypertrophied 14.62 + 1.73 mm) 
and 5% (normal 13.00 + 1.67 mm; hypertro~bied 13.68 2 
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ively. However, none of these changes was 
t. In the right ventricle, there were 18% 
(p K 0.05) and 14% (p = NS) increases in the thickness ofthe 
anterior (normal 4.44 2 0.94 mm; hypertrophied 5.45 f 
1.01 mm) and posterior (nomud 4.44 2 0.72 mm: hypertrophied 
5.05 I 0.91 mm) portions of the wall, respectively. 
Because the direct estimation of chamber volume in 
non-perfusion-fixed tissue is complex and subject to techni- 
cal errors, ventricular ea was calculated and considered to 
provide a ~~sonable estimation ofchamber size (23). The 
calculation ofventricular wall area, which was obtained by 
dividing wall volume by wall thickness, assumes that the 
ventricular wall may be treated as a thin sheet (23). Thus, 
increases in wail area imply huger chamber volumes. Inview 
of the fact that average left and right ventricular wall 
thickness increased 8% (p = NS) and 14% (p = NS) and left 
and right ventricular weight increased 71% and 55%, ven- 
tricular area expanded 60% (p < 0.0001) and 32% (p < 0.01) 
400 
3ao 
100 
0 P 
300 
200 
100 
0 
Conlrol tophi 
HewIs arts 
2. Cross cardiac ~ha~cte~st~cs oft 
resented as mean valu 
z change that is statistically si~n~fi~a~~ (p c 0.05). 
in the left and right sides oft Average 
sarcomere l ngth was not (normal 
1.937 + 0.083 m; hypertrop pm) and 
+ 0.092 m; hy~e~ro~hied 1.921 + 
of the two groups of hearts. In sum- 
senescent heart was characterized by 
biventricular hypertrophy in the presence of ventricular 
ition of the left and 
ted with cardiac hype 
trated in Figure 3. The fractional volumes of myocytes and 
interstitium were found to 0 grou 
of hearts in both the left a ough t
volume percent of the nonmyocyte compartment i creased 
14% and 17% in the leti and right ventricles with myocardial 
hypertrophy, these changes were not statistically significant 
(Fig. 3A). Similarly, the corresponding 3% and 4% decreases 
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nte 
es 
cam 
~onmyocyte com- 
sents the primary measurements utilized for the ~etermi~~- 
I numbers of myocyte 
Tulle 3. Numerical Density and Length of yocyte Nuclei n the Left and Right Vemides 
Control Hypertrophied Difference P 
Hearts Hearts @I Value 
No. of myocyte nuclei/mm’ of myocytes 
Left ventricle 325 f 56 314 + 103 -3 NS 
Right ventricle 341 + 128 391 * lo6 I5 NS 
Average nuclear length (pm) 
Left ventricle 12.62 ? 1.33 15.40 t 2.55 23 < 0.005 
Right ventricle 10.73 + 0.97 12.56 2 1.67 17 < 0.005 
No. of myocyte nuclei/mm” of myocytes 
Left ventricle 25,891 2 4,469 21,329 f 9,288 -18 NS 
Right ventricle 31,818 k 11,264 32,190 + 11,770 1 NS 
Results are presented as mean values f SD. 
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F 4. Changes in the total number of myocyte nuclei in the 
hypertrophied senescent heart. Results are presented as mean 
values 2 SD. *Indicates a change that is statistically significant (p < 
O.O>r. 
pared with nonnal hearts, a statistically ~~goificant di 
regate number of myocyte nuclei was present inthe 
hied hearts. The total number of myocyte nuclei 
iucreased 36% (p < 0.05) and 59% (p < 0.01) in the left and 
right ventricles, respectively. cause cardiac myocytes in 
humans are mostly mononucleated (24-291, and the propor- 
tion between mononucleated and binucleated c lls does not 
markedly inpathologic states (261, most likely these 
es in lei correspond toincreases in myocytes. In 
summary, c ac hypertrophy in the senescent heart is 
characterized bymyocyte cellular hyperplasia biventricu- 
I 
eeyte cell vohnne, The aggregate volume of the myo- 
cyte compartment in each ventricle (Fig. 3D). in combina- 
tion with the ventricular number of myocyte nuclei (Fig. 41, 
was used to compute the mean myocyte cell volume per 
nucleus. Figure 5 illustrates that his variable increased 33% 
(p c 0.05) in the hypertrophied l ft ventricles, whereas the 
expansion i myocyte mass in right ventricles was associ- 
ated with a 2% decrease in cell volume per nucleus. How- 
ever, this latter change was not statistically significant. In
addition, myocyte cell volume per nucleus was 17% (p = 
NS) greater in left than in right ventricular myocytes of 
control subjects, and this difference increased in the dis- 
eased heart. With hypertrophy, myocyte size in the left 
ventricle was 5% (p < 0.005) larger than that in the right 
ventricle, exceeding the variation between the ventricles 
measured atthe ventricular nd total myocyte volume lev- 
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Control 
carts 
5. Charges i 
rtrophied senescent heart. 
0.05). 
e current study indicate 
nd senescent carnal be 
by an increase in the number of myocyte nuclei in the Left and 
right ventricular myocardium, whereas myocyte cellular hy- 
pet-trophy appears tobe restticted to the left ventricle. Tbese 
growth responses of the myocyte population of the myocar- 
dium occur in combination with an increase in the collagen 
compartment of he tissue, so that the ~~~1~0~~ between 
these two structural constituents remains esse 
In addition, the changes inventricular weights 
presence of little morphologic indication of
age, suggesting that the old heart is capable of reacting to 
variations in ventricular loading by expanding itsmuscle mass 
and preserving most of its structural integrity. However, these 
growth ptocesses altered the size and 
leading to ventricular dilation and relative 
which constitute he anatomic counterp 
ec bypertrophy. 
te number and t ic semxe . 
Results in this investigation demonstrate that cardiac hyper- 
trophy in the senescent heart was characterized by a 36% 
and 5% increase inthe aggregate number of myocyte nuclei 
in the left and right ventricles, respectively. This proliiera- 
ogic conditions tha% impose a large and s~s~imed 
the myocardium (7-9). A critical heart weight of 
s been considered the upper limit beyond which 
ers begins (7,32). Alth 
The results of the current study confirm these observations 
(7) and provide support for the concept hat not only the 
adult but also the senescent myocardium ay react to 
mechanical stimuli by increasing its muscle mass through the 
process of myocyte hyperplasia. Recently, similar :.dapta- 
tions have been demonstrated experimentally in rats in the 
aged and senescent bear% (12-l 1 as well as after prolonged 
pressure overload (11,12,33), myocard~a~ infarction (34) aud 
coronary artery constriction (35). Qf relevance in all these 
animal models, ventricular dysfunction and failure were 
present. 
It should be recognized that cardiac hypertropby in humans 
has been shown to be associated whh increases in the percent 
of binucleated celis in both the left and right ventricular 
myocardium (27). This phenomenon would lead to an overes- 
timation of the actual magnitude of myocyte cellular hyperpla- 
increase m myocy%e 
Whetker right ve~tr;c~~ar myocyte 
enlarge further in tb 
established at present. 
synthesis (4) and expression of contractile protein ge 
has been shown experimentally as a f~~cti~~ of age. 
over, in both humans (7-9) and in animal models ( 
myocyte cellular hyperplasia h s been found 80 be couple 
with little or no myocyte cellular hypegrophy. Thus, atten- 
uation ot’ the process of myocyte hype~ro~~y may be 
myocardium (1). 
ypertrophy in the age 
ventricular wall, whereas mural thickness remained essea- 
tially constant inboth ventricles. The presence ofventricular 
dilation and the absence of au increase in wall thic 
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demonstrate that decompensated eccentric hypertrophy de- 
veloped in these hearts (38,39). The expansion i cavitary 
volume may have occurred as a result of an increase in 
length of individual myocytes, the addition in series of newly 
formed cells oras a consequence of an architectural ear- 
rangement of muscle cell layers in the ventricular wall 
(38-40). Scar formation and myocyte loss may also contrib- 
ute to ventricular dilation, which is, however, predominantly 
controlled by changes inmyocyte configuration a d number 
ariations inmyocyte l ngth and diameter 
n the current study, a prevailing increase 
proliferation was most likely involved in the process of 
ventricular dilation bet increase in left vent~c~lar 
wall area exceeded the phic reaction f my 
and cell size was not the right ventricle. 
cell sh d restructuring of the wall characteristically 
occur in response to sudden elevations in ven 
ular diastolic pressure (40,42-44) but are less implicat 
long-term ventricular remodeling (45,466. Therefore, patho- 
logic hypettrophy inthe senescent heart appeat 
result of myocyte lengthening and the longitudin 
of new myocytes, which together participate in the genera- 
tion of a larger cavitaty volume. Cellular eactive growth 
mechanisms are not capable ofmaintaini 
ventricular mass to chamber volume within normal limits, 
myocyte number in the 
alysis of thymidine- and 
n used to d~ument 
whether DNA replication is coupled with nuclear mitotic 
division, ploidy formation r DNA repair. In addition, the 
labeling as an index of cell proliferation 
(47). Finally, alimitation ofthis approach 
bility of demonstrating nuclear division or 
cytokinesis. Flow cytometric measurements of DNA content 
in myocytes also have been used to characterize th  phenom- 
enon of ocyte proliferation in the ventricular myocardium 
04,34). major problems exist with this technique, partic- 
ularly in the case of binucleated cells. Because two adjacent 
diploid nuclei of a binucleated cell may be evaluated together, 
yielding a fake GzM phase count, myocytes first have to be 
isolated. and subsequently the nuclei have to be separated from 
the cytoplasm (143). Moreover, flow cytometry cannot dis- 
tinguish nuclei in G2 from nuclei in the M phase of the cell 
cycle. The appkabiity of this methodology as well as thymi- 
dine or kmkodeox~yuridine labeling of human hearts raises 
We greatly appreciate the expert assistance of Maria Feliciano. 
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